Flushing Financial Corp. (NASDAQ: FFIC) related to its sale to OceanFirst Financial Corp. Under the terms of the proposed transaction, Flushing shareholders are expected to receive 0.85 of a share of ...

Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has ...

After tanking on Novo's "Wegovy Pill" release, Eli Lilly shares reversed course. See why investors may like its acquisition ...

The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...

Eli Lilly is gearing up to announce its fiscal 2025 fourth-quarter earnings in the near term, and analysts project its ...

Shareholders should contact the firm as there may be limited time to enforce your rights. NEW YORK, /PRNewswire/ -- Halper ...

"My pipeline in terms of number of IPOs at the SEC or working to get them into the SEC is bigger than I have ever had in my ...

Detailed price information for Ventyx Biosciences Inc (VTYX-Q) from The Globe and Mail including charting and trades.

Wall St. provides estimates for future stock prices of Eli Lilly from 2026 to 2030 based on projected revenue and net income.

Detailed price information for Ventyx Biosciences Inc (VTYX-Q) from The Globe and Mail including charting and trades.